An internationally renowned working group of retina specialists, ocular imaging experts, and ocular pathologists have suggested standardizing definitions for age-related macular degeneration (AMD) and its subtypes.
As advances in retinal imaging have furthered the understanding of how AMD develops, progresses, and appears, the way researchers and clinicians speak about the disease must evolve with it.
The CONAN group recommends their definitions be immediately incorporated into future clinical trials and studies on AMD. The CONAN group believes that unifying the definitions will help researchers speak the same language across the literature, thereby assisting in comparing trial outcomes and reducing confusion.
Lastly, the group also believes an extension of the proposed terminology will be developed to describe disease severity in neovascular AMD.
1. Spaide RF, Jaffe GJ, Sarraf D, et al. Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group. Ophthalmology 2019 Nov 14. pii: S0161-6420(19)32243-2. doi: 10.1016/j.ophtha.2019.11.004. [Epub ahead of print]
2. Ferris FL, Wilkinson CP, Bird A, et al. Clinical classification of age‐related macular degeneration. Ophthalmology 2013; 120: 844–851.